28 May, 2012

تأثير السمنة و كفاءة الرئتين

تأثير السمنة و كفاءة الرئتين

لنكن صرحاء.. و نعترف بأنه يوجد تأثير واضح للسمنة على الجهاز التنفسي..
صحيح انه توجد أبحاث متناقضة و تتعارض فيما بينها على هذه الموضوع..
دراسات انطلقت في الماضي تفيد بأنه لا علاقة بين السمنة و بين حساسية الصدر و معدلها..
و أبحاث أحدث تؤكد أن السمنة مرض يؤدي إلى تدهور كفاءة الجهاز التنفسي..
و نحن مع هذه النوعية من الدراسات..
إجراء الاختبارات و باستخدام اختبار وظائف التنفس يساعد كثيرا في جلاء الموقف..
المريض ذو الوزن المعتدل يكون أكثر رحابة في كفاءة الجهاز التنفسي..
في حين يعاني المريض البدين من معاناة مستمرة في الجهاز التنفسي..
أرجوك.. عالج موضوع البدانة..
عليك أن تتعامل مع البدانة أنها مرض..
إن تعاملت مع السمنة فان رئتيك ستكون أكثر انتعاشاً و راحة..

Therapeutic implications of obesity
For COPD and asthma
Weight reduction is undoubtedly the optimal health strategy for obese patients with chronic respiratory disease. Approaches to weight loss and weight-loss maintenance have been summarized in various evidence-based reports. In general, therapy comprising diet, physical activity and medication promote a moderate degree of weight or fat loss in the short term. However, the results of studies with long-term follow-up are disappointing because most patients regain some or most of their excess weight. No specific recommendations exist about weight-loss strategies in the presence of respiratory disease. This is not a trivial issue, since patients with chronic respiratory disease are often inactive and therefore often do not comply with the recommendation to increase their levels of physical activity. Incorporating pulmonary rehabilitation and exercise training strategies may therefore help patients begin to exercise, but the efficacy of these approaches in achieving weight loss has not been documented.
The impact of weight reduction on dyspnea, exercise tolerance and quality of life in obese or overweight patients with COPD has not been examined in the literature. In fact, most studies focus on undernourished patients with COPD. With asthma, weight loss has been shown to improve lung function and symptoms, independent of changes in airway hyper-responsiveness. One study that involved 58 obese women, 24 of whom had asthma, demonstrated that for every 10% relative loss of weight, FVC improved by 92 mL (p = 0.05) and the FEV1 improved by 73 mL (p = 0.04). A small randomized trial of the effects of a weight reduction program on obese patients with asthma also showed that an 11% reduction in body weight was associated with a 7.6% improvement in FEV1 compared with the control group (p = 0.02). There is no published evidence of whether therapeutic approaches to COPD or asthma (e.g., inhalation therapy, education and rehabilitation) should be modified in the presence of obesity. However, our experience suggests that the response of obese patients with asthma to pharmacotherapy is often suboptimal, a clinical impression supported by the association between obesity and poor asthma control. Additional studies are required to confirm whether obesity modulates the response to inhalation therapy.


Räumung said...

تسلم ايديك على الموضوع
Räumung - Räumung

entrümpelung wien said...

اتمنى لكم المزيد من التوفيق..
entrümpelung wien